Stefano Curti - Genomma Lab Global President of Brands
| LABB Stock | MXN 14.58 0.48 3.40% |
President
Mr. Stefano Curti serves as Global President of Brands of Genomma Lab Internacional, S.A.B. de C.V. since 2016. He is Global President of Brands at Genomma Lab. He is responsible for the company portfolio of brands and is focused on growth, strategy, innovation, research and development, advertising and design of leading brands. Stefano has more than 27 years of experience in the areas of consumer health, wellness, beauty, OTCs, VC and private equity. Stefano was Global President of Pfizer Consumer Healthcare. Previously, he was President, CEO and Board Member of ExploraMed, an innovation incubator based in Silicon Valley, focused on the development of innovative advances for consumer welfare. Stefano was Global President at Johnson Johnson for the Beauty and Baby divisions. Stefano was also president of J J Consumer USA and General Manager of Neutrogena, where he was responsible for operations in North America. He was also the Managing Director of J J in Europe and Marketing Director for Europe, Africa and the Middle East. since 2016.
| Tenure | 8 years |
| Phone | 52 55 5081 0000 |
| Web | https://www.genommalab.com |
Genomma Lab Management Efficiency
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | PRESIDENT Age | ||
| Daniel Quintanilla | Grupo Mxico SAB | 43 | |
| Carlos Barrera | Alfa SAB de | 68 | |
| Alvaro Garza | Alfa SAB de | 55 | |
| Alfredo Perez | Grupo Mxico SAB | 70 | |
| Paulino Mendivil | Alfa SAB de | 68 | |
| Alejandro Barragan | Alfa SAB de | 64 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 |
Genomma Lab Internacional Leadership Team
Elected by the shareholders, the Genomma Lab's board of directors comprises two types of representatives: Genomma Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genomma. The board's role is to monitor Genomma Lab's management team and ensure that shareholders' interests are well served. Genomma Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genomma Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maximo Juda, CEO, COO and Executive Vice-Pres | ||
| Scott Emerson, Independent Director | ||
| Stefano Curti, Global President of Brands | ||
| Cesar Lopez, Vice President of Global Marketing | ||
| Efran Crdova, Deputy Sec | ||
| Ramon Sastre, Executive Vice President of Institutional Relations | ||
| Carlos Alonso, Independent Director | ||
| Marianne Velasco, Global HR | ||
| Marco Munoz, Non-Member Secretary of the Board of Directors | ||
| Jorge Munoz, Independent Director | ||
| Ignacio Rodriguez, Independent Director | ||
| Alejandro Patino, Executive Vice President of Human Capital and Commercial Expansion | ||
| L Porres, Legal Officer | ||
| Leandro Gold, Independent Director | ||
| Jose Fernandez, Independent Director | ||
| Rodrigo Aspra, Chairman of the Board, Independent Director | ||
| Claudia Vettoretti, Vice-President of Marketing | ||
| Renata Aspra, COO and Executive Vice-Pres | ||
| Juan Gavito, Independent Director | ||
| Antonio Galland, Executive Vice President, Chief Financial and Chief Administrative Officer | ||
| Luis MacKissack, Director | ||
| Arturo Perez, Director | ||
| Hector Gonzalez, Independent Director | ||
| Burkhard Wittek, Director | ||
| Alejandro Patio, Media, Relations | ||
| Marco Sparvieri, Executive Vice-President of Global Sales | ||
| Javier Castilla, Independent Director | ||
| Engineer Galland, Exec CFO | ||
| Sabrina Aspra, Director of International Operations, Director | ||
| Mximo Juda, Advisor | ||
| Daniel Neria, Head Relations | ||
| Juan Alonso, Independent Director | ||
| Santiago Pelaez, Vice President of Industrial and Research and Development | ||
| Jorge Valderrama, Chief Executive Officer | ||
| Juan Sparvieri, Chief Operating Officer, Vice President | ||
| Roberto Sauma, Independent Director | ||
| Leticia Herrera, Global Director of Human Resources (Genomma Experience) |
Genomma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genomma Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 20.43 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 29.00 % | |||
| Shares Owned By Institutions | 29.10 % | |||
| Price To Earning | 13.61 X | |||
| Price To Book | 1.51 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Genomma Stock analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |